1

Zalicus

Zalicus
Leadership team

Julie H. McHugh (Independent Director)

Products/ Services
Biotechnology, Health Care, Medical
Number of Employees
0 - 50
Headquarters
Cambridge, Massachusetts, United States
Established
2000
Traded as
NASDAQ:CRXX
Social Media
Overview
Location
Summary
Zalicus Inc. is a biopharmaceutical company focused on discovering and developing treatments for patients with pain and other diseases. The company's lead product candidate is Z160, a Phase 2 clinical-stage, non-opioid, CNS-selective product candidate for the treatment of moderate-to-severe chronic pain.
History

Zalicus Inc. was founded in 2001 by Dr. Mark H.N. Corrigan to develop novel treatments for pain and other diseases. In 2008, the company announced a merger with CombinatoRx, a clinical-stage biopharmaceutical company focused on the development of novel, synergistic combination therapies. The merger added to Zalicus' pipeline of pain management candidates, which included Z160, Z944 and SYN-115, and expanded its therapeutic areas to include inflammation and immunology. Zalicus has successfully developed a pipeline of clinical-stage product candidates that have the potential to address significant unmet medical needs.

Mission
Our mission is to discover and develop novel treatments for patients with pain and other diseases, to improve the quality of life for patients and their families and to create long-term shareholder value.
Vision
Our vision is to be the premier biopharmaceutical company delivering innovative products that improve the lives of patients with pain and other diseases.
Key Team

Julie H. McHugh (Independent Director)

Recognition and Awards
Zalicus has been the recipient of numerous awards including the Tibbetts Award in 2018, the Prix Galien in 2014, and the Chief Scientist Award in 2011. Zalicus was also recognized in 2013 by Deloitte as one of the top 20 innovative life sciences companies in North America.
References

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Zalicus
Leadership team

Julie H. McHugh (Independent Director)

Products/ Services
Biotechnology, Health Care, Medical
Number of Employees
0 - 50
Headquarters
Cambridge, Massachusetts, United States
Established
2000
Traded as
NASDAQ:CRXX
Social Media